Raffaella Di Lucrezia

This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Lead Discovery Center Gmbh, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Sotio A.s.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raffaella Di Lucrezia. Retrieved from https://idiyas.com/inventor/raffaella-di-lucrezia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 1)

% Patents Active = 66.7

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 6.7

ph-index = 1

Company Filing History:

3 out of 15

Lead Discovery Center Gmbh

patents

2 out of 1,335

Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V.

where one patent can have more than one assignee

Years Active: 2020-2025

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12281079 - Quinoline derivatives, processes for their preparation and uses thereof for the treatment of cancer (2025-04-21),

2. 11111238 - Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer (2021-09-07),

3. 10703735 - 4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer (2020-07-07),

Title: Raffaella Di Lucrezia: Innovator in Cancer Treatment

Introduction

Raffaella Di Lucrezia is a prominent inventor based in Wuppertal, Germany. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel compounds. With a total of three patents to her name, her work focuses on the creation of effective therapeutic agents.

Latest Patents

Raffaella's latest patents include groundbreaking inventions such as quinoline derivatives and coumarin derivatives. The quinoline derivatives are designed for the treatment of cancer, involving compounds of a specific general formula. These compounds can be used as medicaments and are intended for use in combination with other cancer therapies. Additionally, her work on coumarin derivatives presents novel inhibitors of mitochondrial RNA polymerase, which are also aimed at treating cancer.

Career Highlights

Throughout her career, Raffaella has worked with esteemed organizations such as Lead Discovery Center GmbH and the Max Planck Society for the Advancement of Science. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Raffaella has collaborated with notable colleagues, including Tim Bergbrede and Peter Nussbaumer. These partnerships have enhanced her research efforts and fostered innovation in her field.

Conclusion

Raffaella Di Lucrezia stands out as a dedicated inventor whose work is making a difference in cancer treatment. Her innovative patents and collaborations reflect her commitment to advancing medical science.

Profile summary based on public USPTO records.